These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 3129926)

  • 61. Electrophysiologic testing in assessment of therapy with sotalol for sustained ventricular tachycardia.
    Senges J; Lengfelder W; Jauernig R; Czygan E; Brachmann J; Rizos I; Cobbe S; Kübler W
    Circulation; 1984 Mar; 69(3):577-84. PubMed ID: 6692518
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Ethmozine: electrophysiology, hemodynamics, and antiarrhythmic efficacy in patients with life-threatening ventricular arrhythmias.
    Dorian P; Echt DS; Mead RH; Lee JT; Lebsack CS; Winkle RA
    Am Heart J; 1986 Aug; 112(2):327-33. PubMed ID: 3526852
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Flecainide: electrophysiologic and antiarrhythmic properties in refractory ventricular tachycardia.
    Platia EV; Estes M; Heine DL; Griffith LS; Garan H; Ruskin JN; Reid PR
    Am J Cardiol; 1985 Apr; 55(8):956-62. PubMed ID: 3984883
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.
    Mason JW
    N Engl J Med; 1993 Aug; 329(7):452-8. PubMed ID: 8332150
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Acute and chronic antiarrhythmic efficacy of d-sotalol in patients with sustained ventricular tachyarrhythmias.
    Brachmann J; Schöls W; Beyer T; Montero M; Enders B; Kübler W
    Eur Heart J; 1993 Nov; 14 Suppl H():85-7. PubMed ID: 8293757
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Electrophysiologic and clinical factors influencing response to class IA antiarrhythmic agents in patients with inducible sustained monomorphic ventricular tachycardia.
    Gold RL; Haffajee CI; Alpert JS
    Am Heart J; 1986 Jul; 112(1):9-13. PubMed ID: 3728294
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The ESVEM trial. Electrophysiologic Study Versus Electrocardiographic Monitoring for selection of antiarrhythmic therapy of ventricular tachyarrhythmias. The ESVEM Investigators.
    Circulation; 1989 Jun; 79(6):1354-60. PubMed ID: 2655967
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antiarrhythmic drug combinations in the treatment of ventricular tachycardia.
    Ross DL; Sze DY; Keefe DL; Swerdlow CD; Echt DS; Griffin JC; Winkle RA; Mason JW
    Circulation; 1982 Dec; 66(6):1205-10. PubMed ID: 6814784
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Efficacy of sotalol guided by programmed electrical stimulation for sustained ventricular arrhythmias secondary to coronary artery disease.
    Young GD; Kerr CR; Mohama R; Boone J; Yeung-Lai-Wah JA
    Am J Cardiol; 1994 Apr; 73(9):677-82. PubMed ID: 8166065
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparison of noninvasive arrhythmia induction techniques with electrophysiologic studies and evaluation of lorcainide in patients with symptomatic ventricular tachycardia.
    Somberg JC; Butler B; Flowers D; Tepper D; Maguire W; Willens H; Keren G; Miura D
    Am J Cardiol; 1984 Aug; 54(4):49B-54B. PubMed ID: 6465047
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Sotalol for atrial tachycardias after surgery for congenital heart disease.
    Beaufort-Krol GC; Bink-Boelkens MT
    Pacing Clin Electrophysiol; 1997 Aug; 20(8 Pt 2):2125-9. PubMed ID: 9272523
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Efficacy and safety of sotalol for refractory tachyarrhythmias in congenital heart disease.
    Miyazaki A; Ohuchi H; Kurosaki K; Kamakura S; Yagihara T; Yamada O
    Circ J; 2008 Dec; 72(12):1998-2003. PubMed ID: 18931451
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Usefulness of sotalol for drug-refractory malignant ventricular arrhythmias.
    Gonzalez R; Scheinman MM; Herre JM; Griffin JC; Sauve MJ; Sharkey H
    J Am Coll Cardiol; 1988 Dec; 12(6):1568-72. PubMed ID: 3192854
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Lorcainide therapy for the high-risk patient post myocardial infarction.
    Somberg JC; Butler B; Torres V; Flowers D; Tepper D; Keefe D; Miura DS
    Am J Cardiol; 1984 Aug; 54(4):37B-42B. PubMed ID: 6465045
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Efficacy of class Ib (lidocaine-like) antiarrhythmic agents for prevention of sustained ventricular tachycardia secondary to coronary artery disease.
    Reiter MJ; Easley AR; Mann DE
    Am J Cardiol; 1987 Jun; 59(15):1319-24. PubMed ID: 3109228
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Usefulness of the electrophysiology laboratory for evaluation of proarrhythmic drug response in coronary artery disease.
    Buxton AE; Rosenthal ME; Marchlinski FE; Miller JM; Flores B; Josephson ME
    Am J Cardiol; 1991 Apr; 67(9):835-42. PubMed ID: 1707220
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Electrophysiologic evaluation of the antiarrhythmic effects of N-acetylprocainamide for ventricular tachycardia secondary to coronary artery disease.
    Wynn J; Miura DS; Torres V; Flowers D; Keefe D; Williams S; Somberg JC
    Am J Cardiol; 1985 Nov; 56(13):877-81. PubMed ID: 2414983
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The role of EP-guided therapy in ventricular arrhythmias: beta-blockers, sotalol, and ICD's.
    Capucci A; Aschieri D; Villani GQ
    J Interv Card Electrophysiol; 2000 Jan; 4 Suppl 1():57-63. PubMed ID: 10590490
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Antiarrhythmic efficacy of ethmozine in patients with ventricular tachycardia as determined by programmed electrical stimulation.
    Miura DS; Wynn J; Torres V; Laux B; Keefe D; Somberg JC
    Am Heart J; 1986 Apr; 111(4):661-6. PubMed ID: 3513503
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Utility of the signal-averaged electrocardiogram in patients presenting with sustained ventricular tachycardia or fibrillation while on an antiarrhythmic drug.
    Nalos PC; Gang ES; Mandel WJ; Myers MR; Oseran DS; Lass Y; Peter T
    Am Heart J; 1988 Jan; 115(1 Pt 1):108-14. PubMed ID: 3336965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.